Evolving the Principles of Modern Clinical Trial Oversight

Recent global events coupled with the general industry shift to a risk-based quality management approach for clinical trials have demanded a new .. Read more outlook on trial management. Moving from a clinical monitor focus to a truly data-driven approach is essential to ensure that data quality is consistently high – even when unexpected restrictions and abrupt changes arise during a trial. Each part of a study team holds a different piece of the trial management puzzle. Kristin Stallcup brings 15 years of industry experience in various trial management capacities. Currently, she serves as senior director responsible for implementation and adoption of the Xcellerate technology suite into business process. Previously, she served in central monitoring as business lead for the development and implementation of Xcellerate Risk and Issue Management and was also responsible for providing clients with Covance Xcellerate Monitoring methodology and technology implementation. In his previous role, Daniel was responsible for the development and implementation of Xcellerate Data Review.